IPCA Laboratories
Rajendra Dadhich is a seasoned professional with extensive experience in quality assurance within the pharmaceutical industry. Currently serving as Senior Vice President - Corporate Quality at IPCA, Rajendra has previously held significant positions such as Vice President - Corporate QA at IPCA, General Manager - Corporate QA at Wockhardt Ltd., and Senior Manager - Quality Assurance at Ranbaxy Laboratories Ltd. Additionally, Rajendra started the career as a Chemist at POND's (India) Limited and gained early experience as a Sr. Executive - QA at Fulford, an affiliate of Schering Plough. Educational qualifications include an M.Sc. in Chemistry from the University of Mumbai (1983-1985) and a degree in Pharmacy from K M Kundnani College of Pharmacy (1981-1984).
This person is not in any teams
IPCA Laboratories
3 followers
Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is focused on cardio-diabetic market. The Company's activa division serves the rheumatology market. Its altus division caters to the needs of intensivists, both surgical and non-surgical. Its Bionova division's focus area is dermatology. Its dynamix division focuses on cardiovascular, gastro-intestinal, anti-bacterial, pain management and respiratory sectors. It hycare division caters to the needs of cardiologists and diabetologists. Its divisions also include innova, intima, pain management, pharma and uro sciences.